Company Filing History:
Years Active: 2013
Title: Tzu-Chun Cheng: Innovator in Breast Cancer Research
Introduction
Tzu-Chun Cheng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly in the area of breast cancer treatment. His innovative work focuses on the development of small interfering RNAs (siRNAs) that target specific receptors associated with tumorigenesis.
Latest Patents
Tzu-Chun Cheng holds a patent for "Small interfering RNAs and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer." This invention identifies the overexpression and activation of the α9-nAChR receptor as a factor in breast cancer tumorigenesis. The patent outlines methods to inhibit the expression of α9-nAChR using siRNAs, thereby providing a potential therapeutic approach to prevent and treat nicotine-derived compound-induced breast cancer.
Career Highlights
Cheng is affiliated with Taipei Medical University, where he conducts research and develops innovative solutions for cancer treatment. His work has garnered attention for its potential impact on breast cancer therapies, making him a key figure in the medical research community.
Collaborations
Cheng collaborates with notable colleagues, including Chia-Hwa Lee and Ching-Shui Huang, to advance research in cancer treatment and explore new methodologies for combating malignant progression.
Conclusion
Tzu-Chun Cheng's contributions to breast cancer research through his innovative patent highlight the importance of targeted therapies in modern medicine. His work continues to inspire advancements in cancer treatment and offers hope for improved patient outcomes.